Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards Phoenix S&T $1.2M Grant to Develop Protein Separation Device

NEW YORK (GenomeWeb News) – The National Institutes of Health has awarded Phoenix S&T a Phase II Small Business Innovation Research grant to develop a prototype microfluidics device to separate glycoproteins that may be used as biomarkers for cancer and other diseases, the company said last week.
Phoenix S&T said the award is worth as much as $1.2 million over three years.
The company, based in Elkton, Md., said it will use the funds to continue developing a microfluidic chromatographic device that uses nanoparticles as a medium for quickly separating complex proteins. The device will interface with nanospray mass spectrometry to detect and identify proteins, Phoenix S&T added.    
Company president Sau Lan Staats said Phoenix S&T's goal is to make the separation of post-translationally modified proteins "routine and high throughput," which is expected to increase efficiency in many applications.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.